pargyline has been researched along with Hyperglycemia in 2 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Neuvonen, PJ | 1 |
| Westermann, E | 1 |
| Hellman, B | 1 |
| Lernmark, A | 1 |
| Sehlin, J | 1 |
| Täljedal, IB | 1 |
2 other studies available for pargyline and Hyperglycemia
| Article | Year |
|---|---|
Studies on some metabolic effects of dopa and dopamine in the rat.
Topics: Adrenergic beta-Antagonists; Amino Alcohols; Animals; Blood Glucose; Dihydroxyphenylalanine; Dopamin | 1974 |
Transport and storage of 5-hydroxytryptamine in pancreatic -cells.
Topics: Animals; Biological Transport; Carbon Isotopes; Chromatography, Gel; Diazoxide; Glucose; Glyburide; | 1972 |